Inhibition of aromatic L-amino acid decarboxylase activity by human autoantibodies

Clinical and Experimental Immunology

Volumn 120, Issue 3, 2000, Pages 420-423

  Husebye, E S ^c   Boe A S ^d   Rorsman, F ^b   Kampe O ^b   Aakvaag, A ^a   Rygh, T ^a   Flatmark, T ^a   Haavik, J ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UPPSALA UNIVERSITY   (Sweden)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d NONE

Author keywords

Aromatic L amino acid decarboxylase; Autoantigen; Autoimmune polyendocrine syndrome type I; Dopamine; Serotonin

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; AUTOANTIBODY; DECARBOXYLASE INHIBITOR;

ADULT; ARTICLE; AUTOIMMUNITY; CATALYSIS; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; MALE; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANIMALS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; AUTOANTIBODIES; CATALYSIS; CHROMATOGRAPHY, GEL; FEMALE; HUMANS; IMMUNE SERA; MALE; MIDDLE AGED; POLYENDOCRINOPATHIES, AUTOIMMUNE; PROTEIN BIOSYNTHESIS; PYRIDOXAL PHOSPHATE; RATS; TRANSCRIPTION, GENETIC;

EID: 0034130326     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01250.x     Document Type: Article

References (23)

1. 1 Zhu MY, Juorio A. Aromatic L-amino acid decarboxylase: biological characterization and functional role. Gen Pharmacol 1995; 26:681-96.
2. 2 Rahman MK, Nagatsu T, Kato T. Aromatic L-amino acid decarboxylase activity in central and peripheral tissues and serum of rats with L-DOPA and L-5-hydroxytryptophan as substrates. Biochem Pharmacol 1981; 30:645-9.
3. 3 Rorsman F, Husebye ES, Winqvist O, Björk E, Karlsson FA, Kämpe O. Aromatic L-amino acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a novel β-cell autoantigen. Proc Natl Acad Sci USA 1995; 92:8626-9.
4. 4 Husebye ES, Gebre-Medhin G, Tuomi T, Perheentupa J, Landin-Olsson M, Gustafsson J, Rorsman F, Kämpe O. Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 1997; 82:147-50.
5. 5 Gebre-Medhin G, Husebye ES, Gustafsson J, Winqvist O, Goksøyr A, Rorsman F, Kämpe O. Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. FEBS Letters 1997; 412:439-45.
6. 6 Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. Clinical variations or autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Eng J Med 1990; 322:1829-36.
7. 7 Ekwall O, Hedstrand H, Grimelius L et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 1998; 25:279-83.
8. 8 Uversky VN. Use of fast protein size-exclusion liquid chromatography to study the unfolding of proteins which denature through the molten globule. Biochemistry 1993; 32:13288-98.
9. 9 Corbett RJ, Roche RS. Use of high-speed size-exclusion chromatography for the study of protein folding and stability. Biochemistry 1984; 23:1888-94.
10. 10 Flatmark T, Jacobsen SW, Haavik J. Fluorometric detection of tryptophan, 5-hydroxytryptophan, and 5-hydroxytryptamine (serotonin) in high-performance liquid chromatography. Anal Biochem 1980; 107:71-74.
11. 11 Ey PL, Prowse SJ, Jenkin CR. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry 1978; 15:429-36.
12. 12 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
13. 13 Dominici P, Tancini B, Barra D, Voltattorni CB. Purification and characterization of rat-liver 3,4-dihydroxyphenylalanine decarboxylase. Eur J Biochem 1987; 169:209-13.
14. 14 Shirota K, Fujisawa H. Purification and characterization of aromatic L-amino acid decarboxylase from rat kidney and monoclonal antibody to the enzyme. J Neurochem 1988; 51:426-34.
15. 15 Mappouras DC, Stiakakis J, Fragoulis EG. Purification and characterization of L-dopa decarboxylase from human kidney. Mol Cell Biochem 1990; 94:147-56.
16. 16 Jackson RJ. Potassium salts influence the fidelity of mRNA translation initiation in rabbit reticulocyte lysates: unique features of encephalo-myocarditis virus RNA translation. Biochim Biophys Acta 1991; 1088:345-58.
17. 17 Winqvist O, Karlsson FA, Kämpe O. 21-hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 1992; 339:1559-62.
18. 18 Krohn K, Uibo R, Aavik E, Peterson P, Savilahti K. Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase. Lancet 1992; 339:770-3.
19. 19 Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kämpe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest 1993; 92:2377-85.
20. 20 Björk E, Velloso LA, Kämpe O, Karlsson FA. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 1994; 43:161-5.
21. 21 Hedstrand HH, Ekwall O, Haavik J et al. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. Biochem Biophys Res Commun 2000; 267:456-61.
22. 22 Boscaro M, Betterle C, Volpato M, Fallo F, Furmaniak J, Rees Smith B, Sonino N. Hormonal responses during various phases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo. J Clin Endocrinol Metabol 1996; 81:2801-4.
23. 23 Winqvist O, Söderbergh A, Kämpe O. The autoimmune basis of adrenocortical destruction in Addison's disease. Mol Med Today 1996; 2:282-9.